Anti-Cathepsin D antibody
- BOND RX™ Validated
- KO Validated
- What is this?
5
(1 Review)
|
(9 Publications)
Rabbit Polyclonal Cathepsin D antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 9 publications.
View Alternative Names
CPSD, CTSD, Cathepsin D
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin D antibody (AB72915)
IHC image of Cathepsin D staining in human adrenal gland formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab72915, 0.1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cathepsin D antibody (AB72915)
ICC/IF image of ab72915 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Triton for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab72915 at 5μg/ml and ab7291 (Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control) at 1/1000 dilution overnight at +4°C. and ab7291 (Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control) at 1/1000 dilution overnight at +4°C. The secondary antibodies were ab150120 (pseudo-colored red) and ab150081 (colored green) used at 1 μg/ml for 1 hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43 μM for 1hour at room temperature.
- WB
Unknown
Western blot - Anti-Cathepsin D antibody (AB72915)
Cathepsin D has a predicted molecular weight of 45 kDa. The sequence contains a signal sequence and propeptide of 18 and 45 amino acids, respectively. This protein is further cleaved to produce a heavy and light chain with molecular weights of 27 kDa and 11 kDa, respectively (SwissProt). We hypothesize that the observed bands at 29 kDa represent the Cathepsin heavy chain, and the bands at 45 and 48 kDa represent the protein with and without the presence of the signal peptide.
All lanes:
Western blot - Anti-Cathepsin D antibody (ab72915) at 1 µg/mL
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 3:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 44 kDa
Observed band size: 150 kDa,29 kDa,45 kDa,48 kDa,90 kDa
true
Exposure time: 4min
- WB
Lab
Western blot - Anti-Cathepsin D antibody (AB72915)
Lanes 1 - 4 : Merged signal (red and green). Green - ab72915 observed at 28, 43, 46 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab72915 was shown to specifically react with CTSD in wild-type A431 cells as signal was lost in CTSD knockout cells. Wild-type and CTSD knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab72915 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1 μg/ml and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cathepsin D antibody (ab72915) at 1 µg/mL
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
CTSD knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CTSD knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-ctsd-knockout-a-431-cell-line-ab261891'>ab261891</a>)
Lane 3:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Predicted band size: 44 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzymatic activity of Cathepsin D is important for cellular maintenance and apoptosis. This protease does not act within larger protein complexes but contributes to the degradation of extracellular and intracellular proteins. It mediates processes like antigen processing where it deconstructs proteins into peptides that are presented on major histocompatibility complex (MHC) molecules. ELISA tests can quantify its expression levels sometimes termed as CTSD activity in various biological samples offering insights into its role within cellular environments.
Pathways
Cathepsin D involvement includes the lysosomal degradation pathway and the apoptotic signaling pathway. In the lysosomal degradation pathway Cathepsin D breaks down proteins and peptides a process important for cellular recycling and energy release. It interacts with other lysosomal enzymes such as Cathepsin B in this pathway ensuring comprehensive breakdown of cellular waste. The apoptotic signaling pathway involves the regulation of programmed cell death where Cathepsin D can influence the activation of downstream proteins like Bcl-2 and Bax which control cell survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3844 PubMed40274809
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:8638 PubMed39366931
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 96:e0076722 PubMed35770989
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular basis of 1866:165970 PubMed32950675
2020
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 15:1017-1030 PubMed30653408
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 293:3562-3587 PubMed29305422
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 7:2388-2407 PubMed27994678
2016
Applications
IF
Species
Unspecified reactive species
The Journal of biological chemistry 290:9588-603 PubMed25720491
2015
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 289:33568-89 PubMed25301941
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com